These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1087249)

  • 1. Cytotoxic interactions of virus-specific effector cells with virus-infected targets of different cell type [proceedings].
    Koszinowski U; Ertl H
    Folia Biol (Praha); 1976; 22(6):397. PubMed ID: 1087249
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic interactions of virus specific effector cells with virus infected targets of different cell type.
    Koszinowski U; Ertl H
    J Immunogenet; 1977 Apr; 4(2):107-14. PubMed ID: 194984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 4. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model.
    De Boer RJ; Hogeweg P; Dullens HF; De Weger RA; Den Otter W
    J Immunol; 1985 Apr; 134(4):2748-58. PubMed ID: 3156189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increase in the concentration of effector T-lymphocytes specific for H-2 antigens. II. Removal of B-lymphocytes from an eluted population of cytotoxic T-cells].
    Brondz BD; Egorova SG; Kotomina IF
    Tsitologiia; 1976 Dec; 18(12):1484-9. PubMed ID: 799855
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of H-2 antigens in the cytolysis of Oncornavirus induced tumour cells by syngeneic T lymphocytes [proceedings].
    Gomard E; Duprez V; Henin Y; Levy JP
    Folia Biol (Praha); 1976; 22(6):387-8. PubMed ID: 1087248
    [No Abstract]   [Full Text] [Related]  

  • 8. An adherent cell lyses virus-infected targets: characterization, activation, and fine specificity of the cytotoxic cell.
    Letvin NL; Kauffman RS; Finberg R
    J Immunol; 1982 Dec; 129(6):2396-401. PubMed ID: 6292289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of cytotoxic lymphocytes in mixed leukocyte culture systems: introduction.
    Cerottini JC; MacDonald HR; Brunner KT
    Transplant Proc; 1973 Dec; 5(4):1621-4. PubMed ID: 4130070
    [No Abstract]   [Full Text] [Related]  

  • 10. [The H-2 complex, tumor antigens and/or virus-induced antigens].
    Levy JP
    Ann Immunol (Paris); 1977; 128(1-2):493-505. PubMed ID: 66905
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
    Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing immunological responses to experimental allografts.
    Hamburger J; Debray-Sachs M; Dimitriu A; Dy M; Caraux J
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):85-91. PubMed ID: 4280168
    [No Abstract]   [Full Text] [Related]  

  • 16. Accessory cells in the in vitro generation of type C viruses specific T killer lymphocytes. I. Role of macrophages in primary anti-FMR reaction.
    Gomard E; Wybier-Franqui J; Levy JP
    J Immunol; 1981 Mar; 126(3):891-6. PubMed ID: 6257785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of cytotoxic thyroglobulin-specific T cell hybridomas.
    Remy JJ; Texier B; Chiocchia G; Charreire J
    J Immunol; 1989 Feb; 142(4):1129-33. PubMed ID: 2464639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity in flavivirus infections. I. Induction of cytotoxic T lymphocytes in mice by an attenuated virus from the tick-borne encephalitis complex and its group-reactive character.
    Gajdosová E; Oravec C; Mayer V
    Acta Virol; 1981 Jan; 25(1):10-8. PubMed ID: 6165230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.
    Fernández-Cruz E; Pérez M; Zabay JM; Garrido F
    Prog Clin Biol Res; 1987; 244():115-25. PubMed ID: 2958867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.